Stallion India Fluorochemicals Ltd

Stallion India Fluorochemicals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal policy. The window will be shut from October 1st, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. The company will communicate the date of the board meeting to consider these results in due course.

Stallion India Fluorochemicals Ltd has announced the commencement of commercial operations at its new Semiconductor & Specialty Gas debulking and blending facility in Khalapur, Maharashtra. The facility, with an installed capacity of 1,200 MT per annum, began trial runs in early September 2026 and is scheduled for full commercial production from September 21, 2026. This expansion marks the company's entry into the semiconductor and specialty gases market, diversifying its product portfolio and aiming to significantly contribute to future production capacity and revenue growth. The project aligns with the company's Offer objectives disclosed in its January 21, 2026 prospectus.

Stallion India Fluorochemicals Ltd has announced its 24th Annual General Meeting (AGM) will be held on Monday, September 21, 2026, at 04:00 PM IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI circulars. The company has fixed September 16, 2026, as the cut-off date for determining member eligibility for e-voting. The agenda includes adopting financial statements for FY26, re-appointing Mrs. Manisha Shazad Rustomji as a director, and appointing Ms. Swati Ghosh as an Independent Director for a five-year term. The notice of the AGM has been sent to shareholders via email and uploaded on the company's website.

Stallion India Fluorochemicals Ltd has submitted the Monitoring Agency Report for the quarter ended June 30, 2026, concerning the utilization of proceeds from its Rights Issue. The report, issued by Infomerics Valuation and Rating Limited, indicates no deviation from the objects for which the funds were raised. The Rights Issue aggregated to ₹363.93 crore. This filing is in compliance with SEBI regulations regarding the disclosure of issue proceeds utilization.

Stallion India Fluorochemicals Limited (SIFL) reported a strong Q1 FY27 performance with Profit After Tax (PAT) surging 79.15% year-on-year to ₹18.57 crore. Total revenue increased by 12.78% to ₹124.68 crore, while EBITDA grew by 75.85% to ₹25.27 crore. Key operational highlights include the completion of preparations for high-purity helium processing at the Khalapur facility, with commercial operations expected soon. The Mambattu facility is progressing as planned, and the R-32 manufacturing facility at Bhilwara is on track for completion by December 2026. The company anticipates delivering 30-35% revenue CAGR over the next three years, driven by backward integration and higher-value specialty gases.

Stallion India Fluorochemicals Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of its IPO proceeds amounting to ₹160.73 crore. The report, issued by CARE Ratings Limited, indicates no material deviations from the objects disclosed in the Offer Document. While there were initial deviations in 'Issue expenses' and 'purchase of land' versus 'construction of warehouse', these have been addressed and approved by shareholders through Special Resolutions. The company has revised its fund allocation for issue expenses and adjusted capital expenditure plans, with excess utilization within the 10% threshold for certain objects. The report confirms that necessary shareholder approvals have been obtained for revised cost allocations and object modifications.

Stallion India's standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations rose 9.9% YoY and 10.4% QoQ to ₹121.45 Cr. Net profit surged 79.1% YoY (69.8% QoQ) to ₹18.57 Cr, well ahead of topline growth. EPS was ₹1.60 (basic and diluted) against ₹1.15 a year ago and ₹1.33 last quarter. The gain was margin-led. Operating margin expanded to 18.15% from 12.94% a year ago and 14.86% last quarter, while net margin rose to 15.29% from 9.37% YoY. Combined cost of materials consumed and inventory changes fell to ~76.3% of revenue from ~79.5% YoY and ~79.4% QoQ — the principal driver. Other income also rose to ₹3.23 Cr from ₹0.74 Cr YoY on interest from unutilised IPO proceeds parked in fixed deposits (note 5); stripping that out, pre-tax profit still grew ~64% YoY, so the improvement is largely operational rather than a one-off boost. No analyst consensus for this specific print could be confirmed via web search — a pre-results preview (Univest) flagged stabilising realisations as the key swing factor but carried no numeric revenue/PAT estimate, so street comparison is unknown. Against management's own May-2026 framework — a 30-35% three-year revenue CAGR, 3-4 points of margin improvement, and a FY27 PAT target of ₹100-110 Cr — the quarter is mixed: revenue growth of 9.9% YoY trails the guided CAGR pace, but the margin gain (OPM +5.2 points YoY) already exceeds the full multi-year magnitude guided. Annualising Q1 PAT (~₹74 Cr) trails the ₹100-110 Cr FY27 target's low end, though continued margin expansion could close the gap. No separate management press release or commentary accompanied this filing. The board also cleared FY26 corporate-governance items unrelated to operating performance — the secretarial audit report, Directors' Report, MD&A and Corporate Governance Report for FY26, and an AGM set for September 21, 2026, including a proposal to regularise Ms. Swati Ghosh as Woman Independent Director. On IPO-proceeds deployment, ₹10.17 Cr remains unutilised toward the Mambattu (Andhra Pradesh) refrigerant debulking and blending facility, and a May 30, 2026 shareholder resolution redirected the Khalapur allocation toward ~2 acres of land purchase (from a warehouse), a ₹0.13 Cr differential cost — both bear on the capacity build-out behind the long-term revenue guidance.

Stallion India Fluorochemicals Ltd has scheduled a Board of Directors meeting for August 12, 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. Additionally, the trading window for designated persons will remain closed until 48 hours after the declaration of these results, extending to August 14, 2026.

Stallion India Fluorochemicals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal policy. The window will be shut from July 01, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The company will communicate the date of the board meeting to consider these results in due course.

Neomile Corporate Advisory Ltd and Neomile Growth Fund - Series I, through Neomile Asset Managers Pvt. Ltd., have disclosed a sale of shares in Stallion India Fluorochemicals Ltd. The transaction, conducted via open market operations between June 1st and June 4th, 2026, resulted in a reduction of their shareholding. The exact percentage change and final holding details are provided in the disclosure, adhering to SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The acquirers are not part of the promoter group.